"Fluorescein Angiography" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature.
| Descriptor ID |
D005451
|
| MeSH Number(s) |
E01.370.370.050.350 E01.370.380.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fluorescein Angiography".
Below are MeSH descriptors whose meaning is more specific than "Fluorescein Angiography".
This graph shows the total number of publications written about "Fluorescein Angiography" by people in this website by year, and whether "Fluorescein Angiography" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 3 | 3 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 5 | 5 |
| 2008 | 0 | 3 | 3 |
| 2009 | 1 | 1 | 2 |
| 2010 | 0 | 3 | 3 |
| 2011 | 0 | 3 | 3 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 3 | 4 |
| 2014 | 1 | 2 | 3 |
| 2015 | 1 | 4 | 5 |
| 2016 | 0 | 3 | 3 |
| 2017 | 2 | 6 | 8 |
| 2018 | 2 | 8 | 10 |
| 2019 | 4 | 7 | 11 |
| 2020 | 6 | 7 | 13 |
| 2021 | 3 | 14 | 17 |
| 2022 | 1 | 10 | 11 |
| 2023 | 0 | 9 | 9 |
| 2024 | 3 | 6 | 9 |
| 2025 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fluorescein Angiography" by people in Profiles.
-
Quantitative comparison of inner and outer retinal intraretinal hyperreflective foci in age-related macular degeneration. Exp Eye Res. 2025 Jul; 256:110415.
-
Favorable Outcome After Pegcetacoplan (Syfovre)-Associated Occlusive Retinal Vasculitis. Ophthalmic Surg Lasers Imaging Retina. 2025 Mar; 56(3):170-173.
-
Sozinibercept Combination Therapy for Neovascular Age-related Macular Degeneration: Phase 2b Study Subgroup Analysis by Lesion Type. Ophthalmic Surg Lasers Imaging Retina. 2025 May; 56(5):287-296.
-
Emerging clinical evidence of a dual role for Ang-2 and VEGF-A blockade with faricimab in retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2025 May; 263(5):1239-1247.
-
Development of Microcystoid Macular Degeneration in the Retina of Nonhuman Primates: Time-Course and Associated Pathologies. Curr Eye Res. 2025 Jan; 50(1):93-100.
-
MERLIN: Two-Year Results of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid. Ophthalmology. 2025 Feb; 132(2):131-140.
-
Risk factors for development of hyper-reflective foci overlying drusen in eyes with intermediate age-related macular degeneration. Br J Ophthalmol. 2024 Aug 22; 108(9):1234-1239.
-
Spectral-domain OCT characteristics of intraretinal hyper-reflective foci associated with age-related macular degeneration and diabetic retinopathy. Can J Ophthalmol. 2025 Apr; 60(2):91-99.
-
Quantifying Geographic Atrophy in Age-Related Macular Degeneration: A Comparative Analysis Across 12 Deep Learning Models. Invest Ophthalmol Vis Sci. 2024 Jul 01; 65(8):42.
-
Oral Hypoxia-Inducible Factor 2a Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study. Ophthalmology. 2024 Nov; 131(11):1324-1332.